Cough News and Research RSS Feed - Cough News and Research

Guidelines for staying healthy during flu season

Guidelines for staying healthy during flu season

The American Academy of Pediatrics updated its annual influenza (flu) season guidelines, withdrawing the child-friendly nasal flu vaccine, FluMist, this year. [More]
Chronic cough different than cough from cold, says allergist

Chronic cough different than cough from cold, says allergist

There's been a lot of talk about politicians and coughs lately. And we've all seen public figures struggle with it. [More]
People in Europe are most skeptical about vaccines

People in Europe are most skeptical about vaccines

The largest ever global survey of attitudes towards vaccines reported today that public confidence in vaccines varies widely between different regions of the world, with European respondents being most sceptical. [More]
New tool could help reduce antibiotic prescribing to children with cough and RTIs

New tool could help reduce antibiotic prescribing to children with cough and RTIs

Respiratory tract infections (RTI) with cough are the most common reason children are prescribed antibiotics by their doctors, but up to a third of prescriptions may be unnecessary. [More]
Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips Respironics, a division of Royal Philips, will showcase its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 in London (September 3-7). [More]
Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research, have discovered that the number of myeloid-derived suppressor cells (MDSC) is increased in the blood of patients with idiopathic pulmonary fibrosis (IPF). [More]
Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen-Cilag International NV has announced the submission of a Type II variation application to the European Medicines Agency (EMA), seeking to broaden the existing marketing authorisation for the immunotherapy DARZALEX® (daratumumab) to include treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy. The expanded indication is based on daratumumab in combination with lenalidomide (an immmunomodulatory agent) and dexamethasone, or bortezomib (a PI) and dexamethasone. [More]
New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma. [More]
Study explains long-term pulmonary outcomes among childhood cancer survivors

Study explains long-term pulmonary outcomes among childhood cancer survivors

A team of researchers from nine leading academic hospitals and research centers have published a paper in the early online edition of the journal Cancer that describes pulmonary outcomes among childhood cancer survivors. [More]
New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office. [More]
Valley fever diagnosis often overlooked by primary care physicians

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection. [More]
Testing lung health online: an interview with Professor Stephen Holgate

Testing lung health online: an interview with Professor Stephen Holgate

In our latest report – The Battle for Breath – the impact of lung disease in the UK, figures suggest that 1 in 5 (around 12.7 million) have been diagnosed with a lung condition in the UK. If you’re over the age of 70, this rises to 1 in 3. [More]
Exposure to infections in early life not linked to higher mortality risk during adulthood

Exposure to infections in early life not linked to higher mortality risk during adulthood

A new biological study by the University of Stirling has found that exposure to infections in early life does not have long-lasting consequences for later-life survival and reproduction. [More]
New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Researchers develop new technique to help GPs better diagnose UTI in children

Researchers develop new technique to help GPs better diagnose UTI in children

Urinary tract infections (UTI) in young children can lead to kidney damage, but are notoriously difficult to diagnose in primary care because symptoms can often be vague and unclear. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
British Lung Foundation launches exhibition at the houses of parliament

British Lung Foundation launches exhibition at the houses of parliament

A week-long parliamentary exhibition is being held by the British Lung Foundation (BLF) in the Upper Waiting Hall at the houses of parliament from 4-8 July. [More]
Simple 7-item screening device can help detect patients at risk for COPD

Simple 7-item screening device can help detect patients at risk for COPD

A simple 7-item screening tool can help clinicians identify patients at risk for chronic obstructive pulmonary disease (COPD), even if they are not experiencing any symptoms. [More]
Alcohol intoxication perturbs immune system of aged individuals

Alcohol intoxication perturbs immune system of aged individuals

The immune system in the elderly is dysfunctional and infections are more prevalent, more severe, and harder to defeat. Drinking alcohol has a variety of damaging effects on the immune system and organs - like the gut, liver and lung - which can be worsened by pre-existing conditions as well as consumption of prescription and over-the-counter medications that aged individuals often take. [More]
Clinical trial to test efficacy of new drug for chronic cough

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist. [More]
Advertisement
Advertisement